Details for New Drug Application (NDA): 021697
✉ Email this page to a colleague
The generic ingredient in VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is conivaptan hydrochloride. Additional details are available on the conivaptan hydrochloride profile page.
Summary for 021697
Tradename: | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER |
Applicant: | Cumberland |
Ingredient: | conivaptan hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/4ML (5MG/ML) | ||||
Approval Date: | Dec 29, 2005 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/100ML (0.2MG/ML) | ||||
Approval Date: | Oct 8, 2008 | TE: | RLD: | Yes |
Expired US Patents for NDA 021697
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cumberland | VAPRISOL | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-001 | Dec 29, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Cumberland | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-002 | Oct 8, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription